Search research articles
Contact Us
Filters
Showing results (611-620 of 1,257) with videos related to
Page
of 126
Sort By:
The Journal of Biological Chemistry
|
November 12, 2022
Src-mediated phosphorylation of the ribosome biogenesis factor hYVH1 affects its localization, promoting partitioning to the 60S ribosomal subunit
Ashley A DaDalt, Christopher A Bonham, Griffin P Lotze, et al.
Surgery
|
February 21, 2002
Paucity of dendritic cells in pancreatic cancer
Ramsey M Dallal, Peter Christakos, Kenneth Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1993
Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes
W J Storkus, H J Zeh, M J Maeurer, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
February 11, 2005
Reduced frequency of embolic signals in severe carotid stenosis with poststenotic flow velocity reduction
Michael Goertler, Till Blaser, Susanne Guhr, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
May 16, 2006
Expression of androgen-binding protein (ABP) in human cardiac myocytes
H W Schock, Z Herbert, H Sigusch, et al.
Acta Biomaterialia
|
July 6, 2010
Design principles for cytokine-neutralizing gels: Cross-linking effects
Liang Tso Sun, Sidi A Bencherif, Thomas W Gilbert, et al.
American Journal of Respiratory Cell and Molecular Biology
|
March 7, 2009
Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function
Daolin Tang, Rui Kang, Weimin Xiao, et al.
Journal of Pediatric Nursing
|
September 30, 2018
Identifying Opportunities to Provide Family-centered Care for Families With Children With Type 1 Spinal Muscular Atrophy
Diane V Murrell, Claire A Crawford, Chanti T Jackson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1985
In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2
M T Lotze, L W Frana, S O Sharrow, et al.
Cancer
|
March 15, 1985
Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer
A A Rayner, E A Grimm, M T Lotze, et al.
Page
of 126
Search research articles
Search
Showing results (611-620 of 1,257) with videos related to
Sort By:
Page
of 126
The Journal of Biological Chemistry
|
November 12, 2022
Src-mediated phosphorylation of the ribosome biogenesis factor hYVH1 affects its localization, promoting partitioning to the 60S ribosomal subunit
Ashley A DaDalt, Christopher A Bonham, Griffin P Lotze, et al.
Surgery
|
February 21, 2002
Paucity of dendritic cells in pancreatic cancer
Ramsey M Dallal, Peter Christakos, Kenneth Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 1, 1993
Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytes
W J Storkus, H J Zeh, M J Maeurer, et al.
Cerebrovascular Diseases (Basel, Switzerland)
|
February 11, 2005
Reduced frequency of embolic signals in severe carotid stenosis with poststenotic flow velocity reduction
Michael Goertler, Till Blaser, Susanne Guhr, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme
|
May 16, 2006
Expression of androgen-binding protein (ABP) in human cardiac myocytes
H W Schock, Z Herbert, H Sigusch, et al.
Acta Biomaterialia
|
July 6, 2010
Design principles for cytokine-neutralizing gels: Cross-linking effects
Liang Tso Sun, Sidi A Bencherif, Thomas W Gilbert, et al.
American Journal of Respiratory Cell and Molecular Biology
|
March 7, 2009
Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function
Daolin Tang, Rui Kang, Weimin Xiao, et al.
Journal of Pediatric Nursing
|
September 30, 2018
Identifying Opportunities to Provide Family-centered Care for Families With Children With Type 1 Spinal Muscular Atrophy
Diane V Murrell, Claire A Crawford, Chanti T Jackson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1985
In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2
M T Lotze, L W Frana, S O Sharrow, et al.
Cancer
|
March 15, 1985
Lymphokine-activated killer (LAK) cells. Analysis of factors relevant to the immunotherapy of human cancer
A A Rayner, E A Grimm, M T Lotze, et al.
Page
of 126